Trial intelligence / Profile preview

Stepwise discontinuation of levothyroxine in older adults

NL-OMON52395Completed

Sponsor
Leiden University Medical Center
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Leiden University Medical Center. Primary endpoint: Successful withdrawal from thyroid medication at 52 weeks. Started Feb 2020; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NL-OMON52395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON52395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call